Bioscience Equity Partners (BEP), a leading global investment bank, fund and fund manager exclusive to the life sciences sector. At BEP, we not only manage funds for prominent sovereign wealth funds in the Middle East and leading corporate venture capital entities solely focused on early stage life science companies , but we also own and operate our own fund Antisoma. Our primary focus is providing venture capital, equity, and debt financing, tailored to accelerate growth and innovation.



In addition to venture capital, BEP is highly active in mergers and acquisitions (M&A), offering funding, advice and strategic support throughout the transaction process. Our strategic collaborations with global giants reinforce our position as a trusted partner in navigating the complexities of the bioscience industry.